Back
Citius Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
CTXR
Citius Pharmaceuticals
Last Price:
$1.61
Seasonality Move:
-26.14%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and CTXR is experiencing slight buying pressure.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.66 | Sell |
| 20-day SMA: | 1.58 | Buy |
| 50-day SMA: | 1.12 | Buy |
| 200-day SMA: | 3.39 | Sell |
| 8-day EMA: | 1.64 | Sell |
| 20-day EMA: | 1.54 | Buy |
| 50-day EMA: | 1.35 | Buy |
| 200-day EMA: | 4.32 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 54.2 | Buy |
| Chaikin Money Flow: | 173131 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.02 - 1.86) | Buy |
| Bollinger Bands (100): | (0.79 - 1.61) | Buy |
Citius Pharmaceuticals Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
-
Citius Pharmaceuticals share price is 1.60 while CTXR 8-day simple moving average is 1.66, which is a Sell signal.
-
The stock price of CTXR is 1.60 while Citius Pharmaceuticals 20-day SMA is 1.58, which makes it a Buy.
-
Citius Pharmaceuticals 50-day simple moving average is 1.12 while CTXR share price is 1.60, making it a Buy technically.
-
CTXR stock price is 1.60 and Citius Pharmaceuticals 200-day simple moving average is 3.39, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
34
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a SellThe current Citius Pharmaceuticals [CTXR] share price is $1.60. The Score for CTXR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
16.4M
Price in USD:
1.60
Share Volume:
484.8K
Citius Pharmaceuticals 52-Week Range
52-Week High:
26.25
52-Week Low:
0.65
Sell
34
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?The Citius Pharmaceuticals stock price is 1.60 USD today.
-
Will CTXR stock go up or go down?Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
-
Citius Pharmaceuticals share price is 1.60 while CTXR 8-day exponential moving average is 1.64, which is a Sell signal.
-
The stock price of CTXR is 1.60 while Citius Pharmaceuticals 20-day EMA is 1.54, which makes it a Buy.
-
Citius Pharmaceuticals 50-day exponential moving average is 1.35 while CTXR share price is 1.60, making it a Buy technically.
-
CTXR stock price is 1.60 and Citius Pharmaceuticals 200-day simple moving average is 4.32, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $1.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.93 per share, and an increase next year of $0.63 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
-
CTXR Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting Citius Pharmaceuticals is a Buy
-
Citius Pharmaceuticals Relative Strength Index (RSI) is 54.2, which suggest Citius Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Citius Pharmaceuticals is (1.02 - 1.86), which suggest Citius Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Citius Pharmaceuticals is (0.79 - 1.61), which suggest Citius Pharmaceuticals is a Buy
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.